New view on older adults with COVID-19: comments on "SARS-CoV-2 and COVID-19 in older adults: what we may expect regarding pathogenesis, immune responses, and outcomes".
作者信息
Xu Gang, Ye Min, Zhao Jun, Liu Feng, Ma Wei
机构信息
Department of Geriatric Medicine, Guangzhou First People's Hospital, School of Medicine, South China University of Technology, Guangzhou, Guangdong, China.
出版信息
Geroscience. 2020 Oct;42(5):1225-1227. doi: 10.1007/s11357-020-00232-x. Epub 2020 Jul 24.
Abstract
摘要
相似文献
1
New view on older adults with COVID-19: comments on "SARS-CoV-2 and COVID-19 in older adults: what we may expect regarding pathogenesis, immune responses, and outcomes".关于新冠肺炎老年患者的新观点：对《老年人中的SARS-CoV-2和新冠肺炎：关于发病机制、免疫反应及预后我们可能了解到的情况》的评论
Geroscience. 2020 Oct;42(5):1225-1227. doi: 10.1007/s11357-020-00232-x. Epub 2020 Jul 24.
2
The paramount importance of serological surveys of SARS-CoV-2 infection and immunity.新型冠状病毒2（SARS-CoV-2）感染与免疫血清学调查的至关重要性。
Eur J Epidemiol. 2020 Apr;35(4):331-333. doi: 10.1007/s10654-020-00635-2. Epub 2020 Apr 21.
3
Immune status could be associated with severity in COVID-19 patients.免疫状态可能与新冠肺炎患者的病情严重程度相关。
Rev Assoc Med Bras (1992). 2020 Sep 21;66Suppl 2(Suppl 2):13-16. doi: 10.1590/1806-9282.66.S2.13. eCollection 2020.
4
SARS-CoV-2, the Virus that Causes COVID-19: Cytometry and the New Challenge for Global Health.严重急性呼吸综合征冠状病毒2（SARS-CoV-2），即导致2019冠状病毒病（COVID-19）的病毒：细胞计数法与全球健康面临的新挑战
Cytometry A. 2020 Apr;97(4):340-343. doi: 10.1002/cyto.a.24002. Epub 2020 Mar 18.
5
Relation between BCG coverage rate and COVID-19 infection worldwide.全球范围内卡介苗接种率与新冠病毒感染之间的关系。
Med Hypotheses. 2020 Sep;142:109816. doi: 10.1016/j.mehy.2020.109816. Epub 2020 May 6.
6
Cell-Free Therapies: Novel Approaches for COVID-19.无细胞疗法：治疗新冠肺炎的新方法。
Front Immunol. 2020 Sep 18;11:583017. doi: 10.3389/fimmu.2020.583017. eCollection 2020.
7
Is Gradual and Controlled Approach to Herd Protection a Valid Strategy to Curb the COVID-19 Pandemic?逐步且可控的群体保护方法是遏制新冠疫情的有效策略吗？
Indian Pediatr. 2020 Jun 15;57(6):505-507. doi: 10.1007/s13312-020-1844-4. Epub 2020 May 6.
8
COVID-19 - where do we go from here?新冠疫情——我们从这里走向何方？
Singapore Med J. 2020 Jul;61(7):343-344. doi: 10.11622/smedj.2020060. Epub 2020 Apr 17.
9
Will SARS-CoV-2 become endemic?严重急性呼吸综合征冠状病毒2（SARS-CoV-2）会成为地方性流行病吗？
Science. 2020 Oct 30;370(6516):527-529. doi: 10.1126/science.abe5960. Epub 2020 Oct 14.
10
Dynamics of SARS-CoV-2 infection model with two modes of transmission and immune response.具有两种传播模式和免疫反应的 SARS-CoV-2 感染模型的动力学。
Math Biosci Eng. 2020 Aug 11;17(5):5326-5340. doi: 10.3934/mbe.2020288.
引用本文的文献
1
Determinant Factors of Mortality in Pre-elderly and Elderly Patients With COVID-19 in Jakarta, Indonesia.印度尼西亚雅加达的 COVID-19 中老年患者的死亡决定因素。
J Prev Med Public Health. 2023 May;56(3):231-237. doi: 10.3961/jpmph.23.008. Epub 2023 May 31.
2
Role of endocrine PACAP in age-related diseases.内分泌 PACAP 在与年龄相关的疾病中的作用。
Front Endocrinol (Lausanne). 2023 Mar 9;14:1118927. doi: 10.3389/fendo.2023.1118927. eCollection 2023.
3
The Relationship Between Meaning in Life and Health Behaviors in Adults Aged 55 Years and Over During the COVID-19 Pandemic: the Mediating Role of Risk Perception and the Moderating Role of Powerful Others Health Locus of Control.COVID-19 大流行期间 55 岁及以上成年人生活意义与健康行为之间的关系：风险感知的中介作用和重要他人健康控制源的调节作用。
Int J Behav Med. 2023 Jun;30(3):388-397. doi: 10.1007/s12529-022-10100-x. Epub 2022 Jul 1.
4
A Review of the Current Status of Clinical Management of COVID-19 in the Elderly.老年人 COVID-19 临床管理现状综述。
Med Sci Monit. 2021 Apr 9;27:e930278. doi: 10.12659/MSM.930278.
本文引用的文献
1
Clinical findings of patients with coronavirus disease 2019 in Jiangsu province, China: A retrospective, multi-center study.中国江苏省 2019 年冠状病毒病患者的临床特征：一项回顾性、多中心研究。
PLoS Negl Trop Dis. 2020 May 8;14(5):e0008280. doi: 10.1371/journal.pntd.0008280. eCollection 2020 May.
2
Characteristics and Clinical Outcomes of Adult Patients Hospitalized with COVID-19 - Georgia, March 2020.《2020 年 3 月佐治亚州因 COVID-19 住院的成年患者的特征和临床结局》。
MMWR Morb Mortal Wkly Rep. 2020 May 8;69(18):545-550. doi: 10.15585/mmwr.mm6918e1.
3
Risk Factors of Fatal Outcome in Hospitalized Subjects With Coronavirus Disease 2019 From a Nationwide Analysis in China.中国全国范围内分析的 2019 年冠状病毒病住院患者死亡结局的危险因素。
Chest. 2020 Jul;158(1):97-105. doi: 10.1016/j.chest.2020.04.010. Epub 2020 Apr 15.
4
Clinical Characteristics and Outcomes of Older Patients with Coronavirus Disease 2019 (COVID-19) in Wuhan, China: A Single-Centered, Retrospective Study.中国武汉 COVID-19 老年患者的临床特征和结局：一项单中心回顾性研究。
J Gerontol A Biol Sci Med Sci. 2020 Sep 16;75(9):1788-1795. doi: 10.1093/gerona/glaa089.
5
SARS-CoV-2 and COVID-19 in older adults: what we may expect regarding pathogenesis, immune responses, and outcomes.老年人中的 SARS-CoV-2 和 COVID-19：关于发病机制、免疫反应和结局，我们可能会有哪些预期。
Geroscience. 2020 Apr;42(2):505-514. doi: 10.1007/s11357-020-00186-0. Epub 2020 Apr 10.
6
Clinical characteristics and outcomes of hospitalised patients with COVID-19 treated in Hubei (epicentre) and outside Hubei (non-epicentre): a nationwide analysis of China.中国全国范围内的分析：湖北省（疫情中心）和湖北省外（非疫情中心）住院治疗的 COVID-19 患者的临床特征和结局。
Eur Respir J. 2020 Jun 4;55(6). doi: 10.1183/13993003.00562-2020. Print 2020 Jun.
7
Surviving Sepsis Campaign: guidelines on the management of critically ill adults with Coronavirus Disease 2019 (COVID-19).拯救脓毒症运动：2019 冠状病毒病（COVID-19）危重症成人管理指南。
Intensive Care Med. 2020 May;46(5):854-887. doi: 10.1007/s00134-020-06022-5. Epub 2020 Mar 28.
8
Self-reported Olfactory and Taste Disorders in Patients With Severe Acute Respiratory Coronavirus 2 Infection: A Cross-sectional Study.严重急性呼吸综合征冠状病毒2感染患者的自我报告嗅觉和味觉障碍：一项横断面研究。
Clin Infect Dis. 2020 Jul 28;71(15):889-890. doi: 10.1093/cid/ciaa330.
9
Clinical features of COVID-19 in elderly patients: A comparison with young and middle-aged patients.老年 COVID-19 患者的临床特征：与中青年患者的比较。
J Infect. 2020 Jun;80(6):e14-e18. doi: 10.1016/j.jinf.2020.03.005. Epub 2020 Mar 27.
10
Clinical Characteristics of 138 Hospitalized Patients With 2019 Novel Coronavirus-Infected Pneumonia in Wuhan, China.《武汉 2019 年新型冠状病毒感染的肺炎 138 例住院患者临床特征分析》
JAMA. 2020 Mar 17;323(11):1061-1069. doi: 10.1001/jama.2020.1585.
Zotero 插件